Literature DB >> 20479716

IFN-κ, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes.

Correne A DeCarlo1, Alberto Severini, Lutz Edler, Nicholas G Escott, Paul F Lambert, Marina Ulanova, Ingeborg Zehbe.   

Abstract

Interferons (IFNs) are expressed by many cell types and play a pivotal role in the generation of immune responses against viral infections. IFN-κ, a novel type I IFN, displays a tight tropism for keratinocytes and specific lymphoid populations and exhibits functional similarities with other type I IFNs. The human papillomavirus (HPV), the etiological agent for cervical cancer, infects keratinocytes of the uterine cervix and has been shown to directly inhibit the IFN pathway. We evaluated IFN-κ, -β, and -γ gene expression in HPV-negative normal and HPV-positive pre-malignant and malignant ex vivo cervical tissue covering the entire spectrum of cervical disease. Quantitative real-time polymerase chain reaction and methods previously optimized for detecting low-expressing genes in cervical tissue were used. In contrast to IFN-β and -γ, IFN-κ mRNA prevalence and levels were unexpectedly higher in diseased compared with normal whole cervical tissue with highest levels observed in invasive carcinoma tissue. Strikingly, laser capture microdissection revealed an absence of IFN-κ mRNA in diseased epithelium, whereas stromal IFN-κ was found exclusively in diseased tissue. IFN-γ and IFN-β were likewise found to be upregulated in diseased cervical stroma. Immunofluorescence supports the involvement of monocytes and dendritic cells in the stromal induction of IFNs in diseased tissue. Further, using three-dimensional raft cultures in which the viral life cycle can be mimicked, human keratinocytes transfected with full-length HPV16 displayed a significant decrease in IFN-κ mRNA compared with non-transfected human keratinocytes. Altogether, these findings show that IFN-κ is down-regulated in cervical keratinocytes harboring HPV, which may be a contributing factor in the progression of a cervical lesion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20479716     DOI: 10.1038/labinvest.2010.95

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  18 in total

Review 1.  Early Defensive Mechanisms against Human Papillomavirus Infection.

Authors:  Andrea Moerman-Herzog; Mayumi Nakagawa
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

Review 2.  BioAge: toward a multi-determined, mechanistic account of cognitive aging.

Authors:  Correne A DeCarlo; Holly A Tuokko; Dorothy Williams; Roger A Dixon; Stuart W S MacDonald
Journal:  Ageing Res Rev       Date:  2014-09-30       Impact factor: 10.895

3.  Induction of Interferon Kappa in Human Papillomavirus 16 Infection by Transforming Growth Factor Beta-Induced Promoter Demethylation.

Authors:  Brittany L Woodby; William K Songock; Matthew L Scott; Gaurav Raikhy; Jason M Bodily
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

Review 4.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

5.  High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression.

Authors:  Jeanette Reiser; José Hurst; Maike Voges; Peter Krauss; Peter Münch; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

6.  Interferon Kappa Inhibits Human Papillomavirus 31 Transcription by Inducing Sp100 Proteins.

Authors:  Christina Habiger; Günter Jäger; Michael Walter; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

7.  Human Papillomavirus 16 E5 Inhibits Interferon Signaling and Supports Episomal Viral Maintenance.

Authors:  Matthew L Scott; Brittany L Woodby; Joseph Ulicny; Gaurav Raikhy; A Wayne Orr; William K Songock; Jason M Bodily
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

8.  Toll-like receptor transcriptome in the HPV-positive cervical cancer microenvironment.

Authors:  Correne A DeCarlo; Bruce Rosa; Robert Jackson; Sarah Niccoli; Nicholas G Escott; Ingeborg Zehbe
Journal:  Clin Dev Immunol       Date:  2011-10-13

Review 9.  HPV infection: immunological aspects and their utility in future therapy.

Authors:  Efthimios Deligeoroglou; Aikaterini Giannouli; Nikolaos Athanasopoulos; Vasileios Karountzos; Anastasia Vatopoulou; Konstantinos Dimopoulos; George Creatsas
Journal:  Infect Dis Obstet Gynecol       Date:  2013-08-20

10.  E2 proteins of high risk human papillomaviruses down-modulate STING and IFN-κ transcription in keratinocytes.

Authors:  Nuchsupha Sunthamala; Francoise Thierry; Sebastien Teissier; Chamsai Pientong; Bunkerd Kongyingyoes; Thumwadee Tangsiriwatthana; Ussanee Sangkomkamhang; Tipaya Ekalaksananan
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.